Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07321951 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status changed: Recruiting → Active, Not Recruiting Enrollment target: estimated 200 to confirmed 201 · Site details revised at 2 of 2 sitesv4 Show 2 more changesShow less
    • Enrollment target: estimated 200 to confirmed 201
    • Site details revised at 2 of 2 sites
  2. Re-verified, no change to tracked fieldsv3
  3. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Jan 2026 to Jan 9, 2026 · Site details revised at 2 of 2 sitesv2 Show 2 more changesShow less
    • Start date changed from estimate of Jan 2026 to Jan 9, 2026
    • Site details revised at 2 of 2 sites
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This trial was designed to evaluate the efficacy and safety of SHR-1819 in adult patients with moderate-to-severe atopic dermatitis.
Trial Details
NCT Number NCT07321951
Lead Sponsor Guangdong Hengrui Pharmaceutical Co., Ltd
Conditions Moderate-to-severe Atopic Dermatitis
Enrollment 201 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov